Skip to content

Effect of bupivacaine liposome anterior serratus deep block on chronic pain after breast cancer surgery: a randomized controlled study

Effect of bupivacaine liposome anterior serratus deep block on chronic pain after breast cancer surgery: a randomized controlled study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083567
Enrollment
Unknown
Registered
2024-04-28
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

block:Bupivacaine liposomal block
control:Normal anesthesia

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adult patients (aged =18 years) who are scheduled to undergo unilateral modified radical breast cancer surgery

Exclusion criteria

Exclusion criteria: 1. Patients with coagulation dysfunction 2. There are infected patients at the puncture site 3. For patients allergic to any trial drug 4. Patients who take painkillers within 48 hours before surgery 5. Severe cardiopulmonary insufficiency, such as EF< 40%, FEVC < 50% expected; Uncontrolled hypertension; 6. Refuse to perform nerve block puncture 7. Mental disorders, epilepsy history; 8. Unable to give informed consent or are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence of chronic pain 3 months after surgery;

Secondary

MeasureTime frame
Postoperative opioid use;Incidence of postoperative complications;

Countries

China

Contacts

Public ContactGao Feng

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

hualuqiang@163.com+86 185 1747 7764

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026